BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6131914)

  • 1. Evaluation of combined H1- and H2-receptor blocking agents in the treatment of seasonal allergic rhinitis.
    Carpenter GB; Bunker-Soler AL; Nelson HS
    J Allergy Clin Immunol; 1983 Apr; 71(4):412-7. PubMed ID: 6131914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double blind trial of H1 and H2 receptor antagonists in the treatment of atopic dermatitis.
    Frosch PJ; Schwanitz HJ; Macher E
    Arch Dermatol Res; 1984; 276(1):36-40. PubMed ID: 6142700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of topical treatment with H1 and H2 antagonists on clinical symptoms and nasal vascular reactions in patients with allergic rhinitis.
    Holmberg K; Pipkorn U; Bake B; Blychert LO
    Allergy; 1989 May; 44(4):281-7. PubMed ID: 2567579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H1 + H2-receptor antagonists for premedication in anaesthesia and surgery: a critical view based on randomized clinical trials with Haemaccel and various antiallergic drugs.
    Lorenz W; Doenicke A; Schöning B; Mamorski J; Weber D; Hinterlang E; Schwarz B; Neugebauer E
    Agents Actions; 1980 Apr; 10(1 Pt 2):114-24. PubMed ID: 6155762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the actions of H1 and H2 antihistamines on histamine-induced bronchoconstriction and cutaneous wheal response in asthmatic patients.
    Nathan RA; Segall N; Schocket AL
    J Allergy Clin Immunol; 1981 Mar; 67(3):171-7. PubMed ID: 6109741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Greater inhibition of dermographia with a combination of H1 and H2 antagonists.
    Mansfield LE; Smith JA; Nelson HS
    Ann Allergy; 1983 Apr; 50(4):264-5. PubMed ID: 6132569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of SCH 434 and CTM-D in the treatment of seasonal allergic rhinitis.
    Prevost M; Turenne Y; Moote DW; Mazza J; Clermont A; PetitClerc C; Danzig MR
    Clin Ther; 1994; 16(1):50-6. PubMed ID: 7911402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of H1 and H2 antagonists on nasal symptoms and mediator release in atopic patients after nasal allergen challenge during the pollen season.
    Wang D; Clement P; Smitz J
    Acta Otolaryngol; 1996 Jan; 116(1):91-6. PubMed ID: 8820358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activity of recent anti-allergic drugs in the treatment of seasonal allergic rhinitis.
    Wang D; Clement P; Smitz J; De Waele M
    Acta Otorhinolaryngol Belg; 1996; 50(1):25-32. PubMed ID: 8669268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histamine2-antagonists in allergic disorders.
    Heyneman CA
    Ann Pharmacother; 1994 Jun; 28(6):742-3. PubMed ID: 7522657
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of systemically administered H1- and H2-receptor antagonists on nasal blood flow as measured with laser Doppler flowmetry in a provoked allergic reaction.
    Juliusson S; Bende M
    Rhinology; 1996 Mar; 34(1):24-7. PubMed ID: 8739864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis.
    Ratner PH; van Bavel JH; Martin BG; Hampel FC; Howland WC; Rogenes PR; Westlund RE; Bowers BW; Cook CK
    J Fam Pract; 1998 Aug; 47(2):118-25. PubMed ID: 9722799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H2 antihistamines (cimetidine) and allergic-inflammatory reactions.
    Norn S; Permin H; Skov PS
    Allergy; 1980 Jun; 35(4):357-61. PubMed ID: 6160781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the treatment of solar urticaria. The dose-response as a quantifying approach.
    Michell P; Hawk JL; Shafrir A; Corbett MF; Magnus IA
    Dermatologica; 1980; 160(3):198-207. PubMed ID: 6104610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter, double-blind, placebo-controlled trial of terfenadine in seasonal allergic rhinitis and conjunctivitis.
    Kemp JP; Buckley CE; Gershwin ME; Buchman E; Cascio FL; Chretien JH; Foster TS; Gordon WE; Jakle C; Klemawesch SJ
    Ann Allergy; 1985 Jun; 54(6):502-9. PubMed ID: 2861767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dose-ranging study of the efficacy and safety of azelastine nasal spray in the treatment of seasonal allergic rhinitis with an acute model.
    Weiler JM; Meltzer EO; Benson PM; Weiler K; Widlitz MD; Freitag J
    J Allergy Clin Immunol; 1994 Dec; 94(6 Pt 1):972-80. PubMed ID: 7798545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of double-dose antihistamine or combined therapy in allergic rhinitis].
    Li LS; Guan K; Cui L; Wang RQ
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Jan; 32(1):27-32. PubMed ID: 29798206
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of antileukotriene therapy in seasonal allergic rhinitis: a systematic review of randomized trials.
    Rodrigo GJ; Yañez A
    Ann Allergy Asthma Immunol; 2006 Jun; 96(6):779-86. PubMed ID: 16802764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of H1 and H2 blockade on cutaneous histamine response in man.
    Harvey RP; Schocket AL
    J Allergy Clin Immunol; 1980 Feb; 65(2):136-9. PubMed ID: 6101337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical therapeutics: the use of histamine receptor antagonists in contemporary times.
    Obel AO
    East Afr Med J; 1984 Jul; 61(7):578-82. PubMed ID: 6152737
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.